Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Genome plasticity of BCG and impact on vaccine efficacyProceedings of the National Academy of Sciences, 2007
- The Effect of Bacille Calmette‐Guérin Vaccine Strain and Route of Administration on Induced Immune Responses in Vaccinated InfantsThe Journal of Infectious Diseases, 2006
- Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunityVaccine, 2006
- New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical developmentVaccine, 2005
- IL-4 in tuberculosis: implications for vaccine designTrends in Immunology, 2004
- Failure of theMycobacterium bovisBCG Vaccine: Some Species of Environmental Mycobacteria Block Multiplication of BCG and Induction of Protective Immunity to TuberculosisInfection and Immunity, 2002
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- The BCG Story: Lessons from the Past and Implications for the FutureClinical Infectious Diseases, 1989
- BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.BMJ, 1977